Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation

Kidney International

Volumn 79, Issue 10, 2011, Pages 1080-1089

  Caumartin, Yves ^a   Stephen, Jancy ^b   Deng, Jian P ^a   Lian, Dameng ^a   Lan, Zhu ^a   Liu, Weihua ^a   Garcia, Bertha ^a   Jevnikar, Anthony M ^a,c   Wang, Hao ^a,c   Cepinskas, Gediminas ^a,b   Luke, Patrick P W ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

carbon monoxide; ischemia reperfusion injury; kidney transplant

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; CARBON MONOXIDE RELEASING MOLECULE 3; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; GRAFT SURVIVAL; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; NONHUMAN; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; TREATMENT RESPONSE; UPREGULATION;

EID: 79955599892     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.542     Document Type: Article

References (53)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Doyle AM, Lechler RI, Turka LA. Organ transplantation: halfway through the first century. J Am Soc Nephrol 2004; 15: 2965-2971. (Pubitemid 39578827)
3. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289-1295. (Pubitemid 39013575)
4. Meier-Kriesche HU, Schold JD, Srinivas TR et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383. (Pubitemid 38282293)
5. Wolfe RA, Merion RM, Roys EC et al. Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant 2009; 9: 869-878.
6. McCullough KP, Keith DS, Meyer KH et al. Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease. Am J Transplant 2009; 9: 894-906.
7. Nakao A, Choi AM, Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med 2006; 10: 650-671. (Pubitemid 44874275)
8. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005; 57: 585-630. (Pubitemid 43036442)
9. Courtney AE, Maxwell AP. Heme oxygenase 1: does it have a role in renal cytoprotection? Am J Kidney Dis 2008; 51: 678-690. (Pubitemid 351400854)
10. Nakao A, Faleo G, Nalesnik MA et al. Low dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function. Am J Physiol Renal Physiol 2009; 207: F19.
11. Nakao A, Faleo G, Shimizu H et al. Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts. Kidney Int 2008; 74: 1009-1016.
12. Faleo G, Neto JS, Kohmoto J et al. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008; 85: 1833-1840.
13. Martins PN, Reutzel-Selke A, Jurisch A et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation 2006; 82: 938-944. (Pubitemid 44564041)
14. Neto JS, Nakao A, Kimizuka K et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol 2004; 287: F979-F989. (Pubitemid 39391095)
15. Tomiyama K, Ikeda A, Ueki S et al. Inhibition of Kupffer cell-mediated early proinflammatory response with carbon monoxide in transplant-induced hepatic ischemia/reperfusion injury in rats. Hepatology 2008; 48: 1608-1620.
16. Kaizu T, Nakao A, Tsung A et al. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery 2005; 138: 229-235. (Pubitemid 41253805)
17. Nakao A, Toyokawa H, Tsung A et al. Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant 2006; 6: 2243-2255. (Pubitemid 44359410)
18. Nakao A, Kimizuka K, Stolz DB et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 2003; 163: 1587.
19. Zhou HC, Ding WG, Cui XG et al. Carbon monoxide inhalation ameliorates conditions of lung grafts from rat brain death donors. Chin Med J (Engl) 2008; 121: 1411-1498.
20. Kohmoto J, Nakao A, Sugimoto R et al. Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2008; 136: 1067-1075.
21. Kohmoto J, Nakao A, Stolz DB et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant 2007; 7: 2279-2290. (Pubitemid 47347863)
22. Kohmoto J, Nakao A, Kaizu T et al. Low-dose carbon monoxide inhalation prevents ischemia/reperfusion injury of transplanted rat lung grafts. Surgery 2006; 140: 179-185. (Pubitemid 44202625)
23. Nakao A, Toyokawa H, Abe M et al. Heart allograft protection with lowdose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses. Transplantation 2006; 81: 220-230.
24. Nakao A, Kimizuka K, Stolz DB et al. Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts. Surgery 2003; 134: 285-292. (Pubitemid 37070351)
25. Sun B, Sun Z, Jin Q et al. CO-releasing molecules (CORM-2)-liberated CO attenuates leukocytes infiltration in the renal tissue of thermally injured mice. Int J Biol Sci 2008; 4: 176-183. (Pubitemid 351876995)
26. Liu DM, Sun BW, Sun ZW et al. Suppression of inflammatory cytokine production and oxidative stress by CO-releasing molecules-liberated CO in the small intestine of thermally-injured mice. Acta Pharmacol Sin 2008; 29: 838-846.
27. Sun BW, Chen X, Chen ZY et al. Molecular mechanism of inhibition of early pulmonary injury and inflammatory response by exogenous carbon monoxide: experiment with mice. Zhonghua Yi Xue Za Zhi 2007; 87: 3148-3151. (Pubitemid 351188120)
28. Sun BW, Jin Q, Sun Y et al. Carbon liberated from CO-releasing molecules attenuates leukocyte infiltration in the small intestine of thermally injured mice. World J Gastroenterol 2007; 13: 6183-6190.
29. Cepinskas G, Katada K, Bihari A et al. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol 2008; 294: G184-G191.
30. Musameh MD, Green CJ, Mann BE et al. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3). J Heart Lung Transplant 2007; 26: 1192-1198. (Pubitemid 350090021)
31. Stein AB, Guo Y, Tan W et al. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 2005; 38: 127-134. (Pubitemid 40038659)
32. Vera T, Henegar JR, Drummond HA et al. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 2005; 16: 950-958. (Pubitemid 41710305)
33. Bagul A, Hosgood SA, Kaushik M et al. Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney. Transplantation 2008; 85: 576-581.
34. Pizarro MD, Rodriguez JV, Mamprin ME et al. Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation. Cryobiology 2009; 58: 248-255.
35. Sandouka A, Fuller BJ, Mann BE et al. Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int 2006; 69: 239-247. (Pubitemid 43323073)
36. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190: 255-266. (Pubitemid 30141372)
37. Cepinskas G, Lush CW, Kvietys PR. Anoxia/reoxygenation induced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelialo cells. A nuclear factor-kappaB-mediated phenomenon. Circ Res 1999; 84: 103-112. (Pubitemid 29074885)
38. Novitzky D, Cooper DK, Rosendale JD et al. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 2006; 82: 1396-1201.
39. Motterlini R, Mann BE, Johnson TR et al. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 2003; 9: 2525-2539. (Pubitemid 37236371)
40. Guo Y, Stein AB, Wu WJ et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286: H1649-H1653. (Pubitemid 38525450)
41. De Backer O, Elinck E, Blanckaert B et al. Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. Gut 2009; 58: 347-356.
42. Wald N, Idle M, Bailey A. Carboxyhaemoglobin levels and inhaling habits in cigarette smokers. Thorax 1978; 33: 201-206. (Pubitemid 8333492)
43. Foresti R, Bani-Hani MG, Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 2008; 34: 649-658.
44. Sammut IA, Foresti R, Clark JE et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 1998; 125: 1437-1444. (Pubitemid 28548555)
45. Hoetzel A, Dolinay T, Schmidt R et al. Carbon monoxide in sepsis. Antiox Redox Sig 2007; 9: 2013-2026. (Pubitemid 47622349)
46. Kim HP, Ryter SW, Choi AM. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 2006; 46: 411-449. (Pubitemid 43271196)
47. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
48. Otterbein LE, Zuckerbraun BS, Haga M et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183-190. (Pubitemid 36227720)
49. Otterbein LE, Bach FH, Alam J et al. Carbon monoxide has antiinflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-428. (Pubitemid 30208159)
50. Siddiqui I, Khan ZA, Lian D et al. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy. Transplantation 2006; 82: 406-414. (Pubitemid 44223042)
51. Gorin Y, Ricono JM, Kim NH et al. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 2003; 285: F219-F229. (Pubitemid 36871194)
52. Cui XL, Douglas JG. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 1007; 94: 3771-3776.
53. Cepinskas G, Noseworthy R, Kvietys PR. Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement. Circ Res 1997; 81: 618-626. (Pubitemid 27432750)